Procaps Group S.A - Warrants (29/09/2026)
PROCW
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.96M
Close$
Share Statistics
| Market cap | $1.96 Million |
|---|---|
| Enterprise Value | $313.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.42 |
| Beta | 0.17 |
| Outstanding Shares | 101,051,020 |
Return
| Return on Equity | 19211.43% |
|---|---|
| Return on Assets | 8.54% |
| Return on Invested Capital | 73.40% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 0.74 |
| Enterprise Value to EBIT | 6.03 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 1.05 |
| Debt to Equity | 1568.16 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Procaps Group S.A
4,498 employees
CEO: Ruben Minski Procaps Group S.A. is a global pharmaceutical company engaged in the development, manufacturing, and commercialization of a diverse range of medical solutions. The company's portfolio encompasses branded prescription drugs, addressing nu...